Cargando…
Deregulation of N6-Methyladenosine RNA Modification and Its Erasers FTO/ALKBH5 among the Main Renal Cell Tumor Subtypes
(1) Background: Methylation of N(6)-adenosine (m(6)A) is the most abundant messenger RNA (mRNA) modification in eukaryotes. We assessed the expression profiles of m(6)A regulatory proteins in renal cell carcinoma (RCC) and their clinical relevance, namely, as potential biomarkers. (2) Methods: In si...
Autores principales: | Guimarães-Teixeira, Catarina, Barros-Silva, Daniela, Lobo, João, Soares-Fernandes, Diana, Constâncio, Vera, Leite-Silva, Pedro, Silva-Santos, Rui, Braga, Isaac, Henrique, Rui, Miranda-Gonçalves, Vera, Jerónimo, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538585/ https://www.ncbi.nlm.nih.gov/pubmed/34683137 http://dx.doi.org/10.3390/jpm11100996 |
Ejemplares similares
-
Gene Polymorphisms of m6A Erasers FTO and ALKBH1 Associated with Susceptibility to Gastric Cancer
por: Li, Yue, et al.
Publicado: (2022) -
N(6)-methyladenosine demethylases Alkbh5/Fto regulate cerebral ischemia-reperfusion injury
por: Xu, Kaiwei, et al.
Publicado: (2020) -
Identification and Characterization of a Glucometabolic Prognostic Gene Signature in Neuroblastoma based on N6-methyladenosine Eraser ALKBH5
por: Tan, Kezhe, et al.
Publicado: (2022) -
Pan-Cancer Analysis of the N6-Methyladenosine Eraser FTO as a Potential Prognostic and Immunological Biomarker
por: Zhao, Chengwen, et al.
Publicado: (2021) -
Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples
por: Lobo, João, et al.
Publicado: (2021)